HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louise Grybowicz Selected Research

olaparib

4/2024The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louise Grybowicz Research Topics

Disease

1Triple Negative Breast Neoplasms
04/2024
1Residual Neoplasm
01/2017
1Breast Neoplasms (Breast Cancer)
06/2015

Drug/Important Bio-Agent (IBA)

1olaparibIBA
04/2024
1Carboplatin (JM8)FDA LinkGeneric
04/2024
1Paclitaxel (Taxol)FDA LinkGeneric
04/2024
1AnthracyclinesIBA
04/2024
1Bevacizumab (Avastin)FDA Link
06/2015
1Epirubicin (Ellence)FDA LinkGeneric
06/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2015
1Docetaxel (Taxotere)FDA Link
06/2015
1Fluorouracil (Carac)FDA LinkGeneric
06/2015

Therapy/Procedure

2Drug Therapy (Chemotherapy)
04/2024 - 01/2017
2Neoadjuvant Therapy
01/2017 - 06/2015